Format

Send to

Choose Destination
Gastroenterology. 2017 Jan;152(1):300-301. doi: 10.1053/j.gastro.2016.05.060. Epub 2016 Nov 21.

Sofosbuvir and Daclatasvir Anti-Viral Therapy Fails to Clear HEV Viremia and Restore Reactive T Cells in a HEV/HCV Co-Infected Liver Transplant Recipient.

Author information

1
Department of Hepatology and Scottish Liver Transplant Unit, Royal Infirmary of Edinburgh, Edinburgh, UK.
2
Microbiology and Components Group, Scottish National Blood Transfusion Service Research, Development and Innovation, Edinburgh, UK.
3
Centre national de reference Hepatite E, Laboratoire de virology, CHU Toulouse Purpan, Institut Federatif de Biologie, Toulouse, France.
4
Department Of Virology, Royal Infirmary of Edinburgh, Edinburgh, UK.
5
Tissue and Cell Therapy Group, Scottish National Blood Transfusion Service Research, Development and Innovation, Edinburgh, UK.
6
Department of Gastroenterology, Forth Valley Royal, Stirling, UK.
7
Royal Cornwall Hospital, European Centre for Environment and Human Health, University of Exeter, Truro, UK.
8
Departement de Nephrologie et Transplantation d'Organes, CHU Rangueil, Toulouse, France.
9
Department Of Hepatology and Scottish Liver Transplant Unit, Royal Infirmary of Edinburgh, Edinburgh, UK.
PMID:
27883881
DOI:
10.1053/j.gastro.2016.05.060
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center